Clinical trials
Active, not recruiting Phase 3 Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Hoffmann-La Roche | 2 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Bristol-Myers Squibb | 1 |
| CStone Pharmaceuticals | 1 |
| Exelixis | 1 |
| Georgetown University | 1 |
| NRG Oncology | 1 |
| Sun Yat-sen University | 1 |
| UNICANCER | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 17 |
| Liver Neoplasms | 3 |
| Basal Cell Carcinoma | 1 |
| Carcinoma | 1 |
| Carcinoma, Merkel Cell | 1 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Transitional Cell | 1 |
| Colonic Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.